ASCO President Julie Vose, MD, to Give Keynote at AJMC's Patient-Centered Oncology Care Meeting

Published on: 

The fourth annual meeting of Patient-Centered Oncology Care, set for November 19-20, 2015, in Baltimore, Maryland, will feature a premiere multi-stakeholder lineup where leading payers, providers, and leaders from pharma will discuss how to deliver value-based care as cost of breakthrough therapies continues to climb. Julie Vose, MD, MBA, FASCO, the president of the American Society of Clinical Oncology, will give the keynote address.


PLAINSBORO, N.J.—Once again, The American Journal of Managed Care will welcome the president of the American Society of Clinical Oncology (ASCO) as the keynote speaker for its annual meeting of stakeholders involved in seeking better value-based solutions for cancer care. Julie Vose, MD, MBA, FASCO, will address the attendees of Patient-Centered Oncology Care on November 19, 2015, the first day of the two-day conference.

Patient-Centered Oncology Care, now in its fourth year, highlights current issues that cut across the research, insurance, regulatory, policy, pharmacy, and technology realms. The event aims to bring together stakeholders from across the healthcare spectrum—who might otherwise not gather in one place—to find solutions for some of the biggest challenges facing cancer care delivery.

Dr. Vose, an internationally recognized expert in the treatment of lymphoma, is the Neumann M. and Mildred E. Harris Professorial Chair and chief of the oncology/hematology division in the Department of Internal Medicine at the University of Nebraska Medical Center. “This meeting is a unique opportunity for those involved in cancer care to discuss possible solutions to today’s challenges in providing high-quality, high-value treatment,” said Dr. Vose.

Earlier this year, Dr. Vose joined more than 100 oncologists to sign a commentary in the Mayo Clinic Proceedings that supported a patient-driven initiative to lower the cost of cancer drugs. As researchers identify more and more breakthrough treatments for cancer, the rising cost of these therapies has generated debate over how much patients, families, and the healthcare system should pay to save or extend lives.

“A lot of times the physicians actually don’t know what the drugs cost,” Dr. Vose said in an interview with AJMC.


While the price of cancer therapy has received attention in recent months, said Brian Haug, president of AJMC, it is not a new topic at this meeting. “These discussions have been at the heart of Patient-Centered Oncology Care since its inception four year ago,” he said.

For the full agenda and registration information, please visit our conference page,

About the Journals and

The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policy makers, and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.


Nicole Beagin

(609) 716-7777 x 131

About ASCO

Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit Patient-oriented cancer information is available at For more information about cancer-related policy development, please visit

ASCO Contact: Mary Rappaport